

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.01096454 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.01096454 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.65834824 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.65834824 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.23643876 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.57633144 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.57633144 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.57633144 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.37620800 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.26528845 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.23227433 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.15601051 |
| 13 | behavioral response to nicotine (GO:0035095) | 5.14848193 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.04746117 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.94370828 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89052540 |
| 17 | cysteine metabolic process (GO:0006534) | 4.84407442 |
| 18 | regulation of hippo signaling (GO:0035330) | 4.71742440 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.59866748 |
| 20 | aromatic amino acid family metabolic process (GO:0009072) | 4.57146734 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 4.52261189 |
| 22 | bile acid metabolic process (GO:0008206) | 4.44787269 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 4.44476609 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.40230270 |
| 25 | tyrosine metabolic process (GO:0006570) | 4.39877058 |
| 26 | complement activation, alternative pathway (GO:0006957) | 4.38833248 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 4.38739763 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.34788554 |
| 29 | protein carboxylation (GO:0018214) | 4.32469102 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.32469102 |
| 31 | urea cycle (GO:0000050) | 4.29195118 |
| 32 | urea metabolic process (GO:0019627) | 4.29195118 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.26607738 |
| 34 | cellular biogenic amine catabolic process (GO:0042402) | 4.21639971 |
| 35 | amine catabolic process (GO:0009310) | 4.21639971 |
| 36 | negative regulation of fibrinolysis (GO:0051918) | 4.18948693 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.17564841 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.16549945 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.14253407 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.13125935 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.12554874 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.12554874 |
| 43 | indolalkylamine metabolic process (GO:0006586) | 4.08046408 |
| 44 | L-fucose catabolic process (GO:0042355) | 4.05946178 |
| 45 | fucose catabolic process (GO:0019317) | 4.05946178 |
| 46 | L-fucose metabolic process (GO:0042354) | 4.05946178 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.02150092 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 4.01729873 |
| 49 | aldehyde catabolic process (GO:0046185) | 3.99249131 |
| 50 | coenzyme catabolic process (GO:0009109) | 3.96849491 |
| 51 | lysine metabolic process (GO:0006553) | 3.96768891 |
| 52 | lysine catabolic process (GO:0006554) | 3.96768891 |
| 53 | fatty acid elongation (GO:0030497) | 3.93797624 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 3.91169872 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 3.91169872 |
| 56 | macromolecular complex remodeling (GO:0034367) | 3.91169872 |
| 57 | DNA deamination (GO:0045006) | 3.88727272 |
| 58 | drug transmembrane transport (GO:0006855) | 3.88620157 |
| 59 | ethanol oxidation (GO:0006069) | 3.88427929 |
| 60 | reverse cholesterol transport (GO:0043691) | 3.87050814 |
| 61 | regulation of complement activation (GO:0030449) | 3.87017233 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 3.85748675 |
| 63 | phospholipid efflux (GO:0033700) | 3.85665747 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.85195437 |
| 65 | very long-chain fatty acid metabolic process (GO:0000038) | 3.85138515 |
| 66 | ketone body metabolic process (GO:1902224) | 3.82720753 |
| 67 | cellular glucuronidation (GO:0052695) | 3.78308487 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 3.77687492 |
| 69 | fatty acid oxidation (GO:0019395) | 3.75961150 |
| 70 | acetyl-CoA metabolic process (GO:0006084) | 3.75621832 |
| 71 | urate metabolic process (GO:0046415) | 3.74045438 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 3.72329832 |
| 73 | bile acid and bile salt transport (GO:0015721) | 3.70993920 |
| 74 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.70826379 |
| 75 | fatty acid catabolic process (GO:0009062) | 3.70784210 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.69732922 |
| 77 | lipid oxidation (GO:0034440) | 3.69349632 |
| 78 | carboxylic acid catabolic process (GO:0046395) | 3.65534654 |
| 79 | organic acid catabolic process (GO:0016054) | 3.65534654 |
| 80 | serine family amino acid biosynthetic process (GO:0009070) | 3.64070985 |
| 81 | monocarboxylic acid catabolic process (GO:0072329) | 3.63831600 |
| 82 | signal peptide processing (GO:0006465) | 3.63340557 |
| 83 | NAD biosynthetic process (GO:0009435) | 3.61917746 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60988851 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60988851 |
| 86 | heme transport (GO:0015886) | 3.58663255 |
| 87 | uronic acid metabolic process (GO:0006063) | 3.57488604 |
| 88 | glucuronate metabolic process (GO:0019585) | 3.57488604 |
| 89 | drug catabolic process (GO:0042737) | 3.53636520 |
| 90 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.53624157 |
| 91 | glutamate metabolic process (GO:0006536) | 3.53467145 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 3.53071702 |
| 93 | cofactor catabolic process (GO:0051187) | 3.52245993 |
| 94 | branched-chain amino acid catabolic process (GO:0009083) | 3.52012668 |
| 95 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.49494017 |
| 96 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.49494017 |
| 97 | cholesterol efflux (GO:0033344) | 3.48757808 |
| 98 | negative regulation of cholesterol transport (GO:0032375) | 3.46878654 |
| 99 | negative regulation of sterol transport (GO:0032372) | 3.46878654 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.45234249 |
| 101 | cellular modified amino acid catabolic process (GO:0042219) | 3.44576958 |
| 102 | neuronal action potential (GO:0019228) | 3.43263335 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 3.41701354 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.40925007 |
| 105 | glycine metabolic process (GO:0006544) | 3.39271940 |
| 106 | fibrinolysis (GO:0042730) | 3.36633020 |
| 107 | opsonization (GO:0008228) | 3.35718301 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.34352265 |
| 109 | carnitine metabolic process (GO:0009437) | 3.33314186 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.32913835 |
| 111 | response to pheromone (GO:0019236) | 3.29566057 |
| 112 | indole-containing compound metabolic process (GO:0042430) | 3.24916945 |
| 113 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.24870307 |
| 114 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.16947899 |
| 115 | axoneme assembly (GO:0035082) | 3.14838215 |
| 116 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.09254672 |
| 117 | detection of light stimulus involved in visual perception (GO:0050908) | 3.09254672 |
| 118 | protein complex biogenesis (GO:0070271) | 3.08885346 |
| 119 | cornea development in camera-type eye (GO:0061303) | 3.08720123 |
| 120 | peristalsis (GO:0030432) | 3.06126659 |
| 121 | sulfation (GO:0051923) | 3.05665504 |
| 122 | mannosylation (GO:0097502) | 3.04748866 |
| 123 | multicellular organism reproduction (GO:0032504) | 3.03767083 |
| 124 | prostate gland growth (GO:0060736) | 3.02364076 |
| 125 | phasic smooth muscle contraction (GO:0014821) | 3.01527648 |
| 126 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.92919360 |
| 127 | neural tube formation (GO:0001841) | 2.91906484 |
| 128 | protein polyglutamylation (GO:0018095) | 2.90410204 |
| 129 | piRNA metabolic process (GO:0034587) | 2.89303933 |
| 130 | urinary tract smooth muscle contraction (GO:0014848) | 2.86787609 |
| 131 | serotonin metabolic process (GO:0042428) | 2.86069046 |
| 132 | respiratory chain complex IV assembly (GO:0008535) | 2.83949258 |
| 133 | regulation of action potential (GO:0098900) | 2.81622650 |
| 134 | negative regulation of telomere maintenance (GO:0032205) | 2.81461758 |
| 135 | cellular response to ATP (GO:0071318) | 2.80424140 |
| 136 | primary amino compound metabolic process (GO:1901160) | 2.78473706 |
| 137 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.77901943 |
| 138 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.77573087 |
| 139 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.77011281 |
| 140 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.76651593 |
| 141 | NADH dehydrogenase complex assembly (GO:0010257) | 2.76651593 |
| 142 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.76651593 |
| 143 | oxidative demethylation (GO:0070989) | 2.76219534 |
| 144 | S-adenosylmethionine metabolic process (GO:0046500) | 2.76107311 |
| 145 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.75201771 |
| 146 | ubiquinone biosynthetic process (GO:0006744) | 2.73087739 |
| 147 | thyroid hormone metabolic process (GO:0042403) | 2.72829154 |
| 148 | reflex (GO:0060004) | 2.71736057 |
| 149 | cytochrome complex assembly (GO:0017004) | 2.71040213 |
| 150 | photoreceptor cell maintenance (GO:0045494) | 2.70505163 |
| 151 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.70482708 |
| 152 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.70482708 |
| 153 | behavioral response to ethanol (GO:0048149) | 2.70187675 |
| 154 | GPI anchor metabolic process (GO:0006505) | 2.69290321 |
| 155 | flavonoid metabolic process (GO:0009812) | 2.66492720 |
| 156 | gamma-aminobutyric acid transport (GO:0015812) | 2.66212177 |
| 157 | platelet dense granule organization (GO:0060155) | 2.65380592 |
| 158 | epithelial cilium movement (GO:0003351) | 2.62057540 |
| 159 | embryonic epithelial tube formation (GO:0001838) | 2.60864100 |
| 160 | positive regulation of fatty acid transport (GO:2000193) | 2.60073780 |
| 161 | C-terminal protein lipidation (GO:0006501) | 2.58162629 |
| 162 | phenylpropanoid metabolic process (GO:0009698) | 2.58071950 |
| 163 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.54464624 |
| 164 | parturition (GO:0007567) | 2.45328825 |
| 165 | DNA methylation involved in gamete generation (GO:0043046) | 2.45063559 |
| 166 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.44651177 |
| 167 | sphingoid metabolic process (GO:0046519) | 2.43764356 |
| 168 | ubiquinone metabolic process (GO:0006743) | 2.43465191 |
| 169 | C-terminal protein amino acid modification (GO:0018410) | 2.42680673 |
| 170 | rhodopsin mediated signaling pathway (GO:0016056) | 2.41718924 |
| 171 | cilium organization (GO:0044782) | 2.41177522 |
| 172 | keratinocyte development (GO:0003334) | 2.41108203 |
| 173 | auditory receptor cell stereocilium organization (GO:0060088) | 2.40962780 |
| 174 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.40458605 |
| 175 | nucleotide transmembrane transport (GO:1901679) | 2.39580206 |
| 176 | xenobiotic catabolic process (GO:0042178) | 2.38913136 |
| 177 | nonmotile primary cilium assembly (GO:0035058) | 2.37681065 |
| 178 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.37597918 |
| 179 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.37588161 |
| 180 | cilium morphogenesis (GO:0060271) | 2.37479738 |
| 181 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.37359492 |
| 182 | cilium movement (GO:0003341) | 2.36817788 |
| 183 | valine metabolic process (GO:0006573) | 2.36629968 |
| 184 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.36521278 |
| 185 | L-methionine biosynthetic process (GO:0071265) | 2.35466567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.69236063 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.83733490 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.43216252 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.74085839 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.32361020 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.12826539 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.57744187 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.47541324 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.90076048 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.50399874 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.44184421 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.03984063 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.78607681 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.20627240 |
| 15 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.08330439 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.02825176 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.01882126 |
| 18 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98622872 |
| 19 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.89968117 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86422475 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85822168 |
| 22 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84368558 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83833238 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83632808 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.79218839 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.75898918 |
| 27 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.73132586 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.72489590 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68967783 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.65598749 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65242177 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.65144273 |
| 33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64158508 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60266759 |
| 35 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.52764465 |
| 36 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.52764465 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51773217 |
| 38 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.51647253 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.50972624 |
| 40 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50882104 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50710187 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48376400 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47745039 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45104027 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42590058 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42590058 |
| 47 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 1.39365303 |
| 48 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.39353905 |
| 49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39041898 |
| 50 | TCF4_23295773_ChIP-Seq_U87_Human | 1.38900717 |
| 51 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38811628 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35935284 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35296661 |
| 54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35135464 |
| 55 | NCOR_22424771_ChIP-Seq_293T_Human | 1.35089012 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34005232 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32917192 |
| 58 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.32615107 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29220046 |
| 60 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.29167944 |
| 61 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26584657 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26276009 |
| 63 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.25399103 |
| 64 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22876912 |
| 65 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22876912 |
| 66 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22832544 |
| 67 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21308000 |
| 68 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20371908 |
| 69 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19526454 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19461728 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18502541 |
| 72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16894457 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16785291 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.16324494 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14806569 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14727565 |
| 77 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14625755 |
| 78 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13463747 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13193148 |
| 80 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.12869312 |
| 81 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12854471 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12354252 |
| 83 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.11958094 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11337143 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10878557 |
| 86 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.09501127 |
| 87 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07454040 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06876079 |
| 89 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04308241 |
| 90 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.02288641 |
| 91 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02165387 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02089760 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01839116 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01061923 |
| 95 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99900605 |
| 96 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97255242 |
| 97 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95271793 |
| 98 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94853664 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94702009 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94591055 |
| 101 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.94376626 |
| 102 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.93664029 |
| 103 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93614951 |
| 104 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93532602 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93510133 |
| 106 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92883402 |
| 107 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92453394 |
| 108 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90049505 |
| 109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89641126 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88667472 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88667472 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88037743 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.85953782 |
| 114 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85794577 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85766979 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85345461 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85113826 |
| 118 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84483295 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.82291489 |
| 120 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82047311 |
| 121 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80334951 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.80171964 |
| 123 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80092018 |
| 124 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.79910065 |
| 125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79760741 |
| 126 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.79621934 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79581026 |
| 128 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.79238758 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.78056299 |
| 130 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77873405 |
| 131 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77042748 |
| 132 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.76811982 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76739057 |
| 134 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76497187 |
| 135 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.76307397 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75391297 |
| 137 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.73748278 |
| 138 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.72835084 |
| 139 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.72627159 |
| 140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.71770878 |
| 141 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.71225144 |
| 142 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.70948264 |
| 143 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69584763 |
| 144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68486071 |
| 145 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.67931004 |
| 146 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66470928 |
| 147 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66461323 |
| 148 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.66384734 |
| 149 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65397664 |
| 150 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.65165959 |
| 151 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.64919296 |
| 152 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64853724 |
| 153 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.64530051 |
| 154 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.64009543 |
| 155 | CBP_21632823_ChIP-Seq_H3396_Human | 0.63900766 |
| 156 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63668088 |
| 157 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63175169 |
| 158 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62126958 |
| 159 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.61455202 |
| 160 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.61183115 |
| 161 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.60728952 |
| 162 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.60441155 |
| 163 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.60441155 |
| 164 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.60276123 |
| 165 | VDR_22108803_ChIP-Seq_LS180_Human | 0.59891920 |
| 166 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.59528619 |
| 167 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.59205928 |
| 168 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.58685907 |
| 169 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.58203765 |
| 170 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.57536062 |
| 171 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.57337467 |
| 172 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.57140476 |
| 173 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.56550654 |
| 174 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.56207639 |
| 175 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.56163051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.47134630 |
| 2 | MP0005360_urolithiasis | 6.85190691 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.63611180 |
| 4 | MP0005365_abnormal_bile_salt | 5.37711381 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.49890996 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.00258456 |
| 7 | MP0003252_abnormal_bile_duct | 3.42668443 |
| 8 | MP0003195_calcinosis | 3.22918630 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.10127004 |
| 10 | MP0000427_abnormal_hair_cycle | 3.02616207 |
| 11 | MP0005332_abnormal_amino_acid | 2.85699769 |
| 12 | MP0005083_abnormal_biliary_tract | 2.64505346 |
| 13 | MP0009840_abnormal_foam_cell | 2.64463914 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.61064965 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.50103651 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.43370577 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.40990301 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.38359700 |
| 19 | MP0002638_abnormal_pupillary_reflex | 2.25982857 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.16834814 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 2.10903921 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.07756757 |
| 23 | MP0008872_abnormal_physiological_respon | 1.98048443 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.94234051 |
| 25 | MP0003646_muscle_fatigue | 1.93336231 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.92662810 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.87697479 |
| 28 | MP0001764_abnormal_homeostasis | 1.87373482 |
| 29 | MP0005451_abnormal_body_composition | 1.86062986 |
| 30 | MP0000609_abnormal_liver_physiology | 1.84484207 |
| 31 | MP0000383_abnormal_hair_follicle | 1.80718212 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.79825963 |
| 33 | MP0002736_abnormal_nociception_after | 1.78679234 |
| 34 | MP0003186_abnormal_redox_activity | 1.76335185 |
| 35 | MP0003011_delayed_dark_adaptation | 1.69819054 |
| 36 | MP0004885_abnormal_endolymph | 1.65360391 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.62753988 |
| 38 | MP0009745_abnormal_behavioral_response | 1.62377436 |
| 39 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.62286450 |
| 40 | MP0003868_abnormal_feces_composition | 1.60035068 |
| 41 | MP0004145_abnormal_muscle_electrophysio | 1.58195952 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.54425466 |
| 43 | MP0002163_abnormal_gland_morphology | 1.53761223 |
| 44 | MP0000647_abnormal_sebaceous_gland | 1.53658326 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.53223840 |
| 46 | MP0009697_abnormal_copulation | 1.52968108 |
| 47 | MP0009046_muscle_twitch | 1.52873639 |
| 48 | MP0008877_abnormal_DNA_methylation | 1.52213623 |
| 49 | MP0004381_abnormal_hair_follicle | 1.50540649 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.50184002 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.49943724 |
| 52 | MP0000631_abnormal_neuroendocrine_gland | 1.48849156 |
| 53 | MP0001346_abnormal_lacrimal_gland | 1.47169327 |
| 54 | MP0005670_abnormal_white_adipose | 1.46283430 |
| 55 | MP0002938_white_spotting | 1.42325823 |
| 56 | MP0005253_abnormal_eye_physiology | 1.38849672 |
| 57 | MP0006276_abnormal_autonomic_nervous | 1.37319956 |
| 58 | MP0001919_abnormal_reproductive_system | 1.37006111 |
| 59 | MP0010678_abnormal_skin_adnexa | 1.35667072 |
| 60 | MP0003787_abnormal_imprinting | 1.35281610 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.33185791 |
| 62 | MP0003045_fibrosis | 1.32849173 |
| 63 | MP0009379_abnormal_foot_pigmentation | 1.32498229 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.31032651 |
| 65 | MP0010386_abnormal_urinary_bladder | 1.30535631 |
| 66 | MP0003724_increased_susceptibility_to | 1.30006941 |
| 67 | MP0005389_reproductive_system_phenotype | 1.28745891 |
| 68 | MP0002102_abnormal_ear_morphology | 1.28445930 |
| 69 | MP0002272_abnormal_nervous_system | 1.26681271 |
| 70 | MP0001501_abnormal_sleep_pattern | 1.26678139 |
| 71 | MP0004142_abnormal_muscle_tone | 1.25204307 |
| 72 | MP0008995_early_reproductive_senescence | 1.23893985 |
| 73 | MP0002095_abnormal_skin_pigmentation | 1.23847680 |
| 74 | MP0009764_decreased_sensitivity_to | 1.19464000 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.18510576 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.16619044 |
| 77 | MP0004133_heterotaxia | 1.15236266 |
| 78 | MP0005647_abnormal_sex_gland | 1.12841288 |
| 79 | MP0001664_abnormal_digestion | 1.12715193 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 1.12027194 |
| 81 | MP0002160_abnormal_reproductive_system | 1.11103227 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 1.08854305 |
| 83 | MP0008057_abnormal_DNA_replication | 1.08633402 |
| 84 | MP0006292_abnormal_olfactory_placode | 1.08629570 |
| 85 | MP0005408_hypopigmentation | 1.05269638 |
| 86 | MP0005310_abnormal_salivary_gland | 1.04644951 |
| 87 | MP0004043_abnormal_pH_regulation | 1.02718125 |
| 88 | MP0001873_stomach_inflammation | 1.02606875 |
| 89 | MP0008775_abnormal_heart_ventricle | 1.01714547 |
| 90 | MP0000566_synostosis | 1.00906473 |
| 91 | MP0002557_abnormal_social/conspecific_i | 0.99787434 |
| 92 | MP0005410_abnormal_fertilization | 0.97906778 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.96515121 |
| 94 | MP0001661_extended_life_span | 0.96254450 |
| 95 | MP0008469_abnormal_protein_level | 0.95352552 |
| 96 | MP0009763_increased_sensitivity_to | 0.92997874 |
| 97 | MP0003878_abnormal_ear_physiology | 0.92504878 |
| 98 | MP0005377_hearing/vestibular/ear_phenot | 0.92504878 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.92305724 |
| 100 | MP0002733_abnormal_thermal_nociception | 0.91875062 |
| 101 | MP0003690_abnormal_glial_cell | 0.91537797 |
| 102 | MP0001970_abnormal_pain_threshold | 0.90667419 |
| 103 | MP0002572_abnormal_emotion/affect_behav | 0.89292682 |
| 104 | MP0005535_abnormal_body_temperature | 0.88184390 |
| 105 | MP0004147_increased_porphyrin_level | 0.86143361 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.85839837 |
| 107 | MP0002067_abnormal_sensory_capabilities | 0.85473408 |
| 108 | MP0002751_abnormal_autonomic_nervous | 0.85309353 |
| 109 | MP0002064_seizures | 0.84651302 |
| 110 | MP0009642_abnormal_blood_homeostasis | 0.84587650 |
| 111 | MP0002282_abnormal_trachea_morphology | 0.84415746 |
| 112 | MP0000598_abnormal_liver_morphology | 0.83971341 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.83678120 |
| 114 | MP0005334_abnormal_fat_pad | 0.83083529 |
| 115 | MP0001756_abnormal_urination | 0.82875209 |
| 116 | MP0002254_reproductive_system_inflammat | 0.82785867 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.82451456 |
| 118 | MP0004924_abnormal_behavior | 0.82451456 |
| 119 | MP0002971_abnormal_brown_adipose | 0.82433566 |
| 120 | MP0001905_abnormal_dopamine_level | 0.82085769 |
| 121 | MP0001486_abnormal_startle_reflex | 0.81847059 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.81657646 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.80692806 |
| 124 | MP0002277_abnormal_respiratory_mucosa | 0.79880266 |
| 125 | MP0005376_homeostasis/metabolism_phenot | 0.79165668 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.78745026 |
| 127 | MP0005409_darkened_coat_color | 0.74671921 |
| 128 | MP0003718_maternal_effect | 0.73415119 |
| 129 | MP0002796_impaired_skin_barrier | 0.73318198 |
| 130 | MP0002132_abnormal_respiratory_system | 0.73279400 |
| 131 | MP0005075_abnormal_melanosome_morpholog | 0.73001039 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.72984599 |
| 133 | MP0000920_abnormal_myelination | 0.71639531 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.68723574 |
| 135 | MP0002078_abnormal_glucose_homeostasis | 0.67984132 |
| 136 | MP0010368_abnormal_lymphatic_system | 0.65384485 |
| 137 | MP0004130_abnormal_muscle_cell | 0.64685242 |
| 138 | MP0000604_amyloidosis | 0.63353960 |
| 139 | MP0005395_other_phenotype | 0.63177135 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.61903784 |
| 141 | MP0001765_abnormal_ion_homeostasis | 0.60007450 |
| 142 | MP0002837_dystrophic_cardiac_calcinosis | 0.59600341 |
| 143 | MP0005379_endocrine/exocrine_gland_phen | 0.58635249 |
| 144 | MP0005220_abnormal_exocrine_pancreas | 0.58193698 |
| 145 | MP0000579_abnormal_nail_morphology | 0.54905288 |
| 146 | MP0006082_CNS_inflammation | 0.53676394 |
| 147 | MP0005266_abnormal_metabolism | 0.53131582 |
| 148 | MP0002928_abnormal_bile_duct | 0.52510932 |
| 149 | MP0003136_yellow_coat_color | 0.51604647 |
| 150 | MP0001881_abnormal_mammary_gland | 0.51553436 |
| 151 | MP0006035_abnormal_mitochondrial_morpho | 0.51273960 |
| 152 | MP0003638_abnormal_response/metabolism_ | 0.50963298 |
| 153 | MP0005448_abnormal_energy_balance | 0.50809457 |
| 154 | MP0001853_heart_inflammation | 0.47316076 |
| 155 | MP0001986_abnormal_taste_sensitivity | 0.47264097 |
| 156 | MP0000639_abnormal_adrenal_gland | 0.46138950 |
| 157 | MP0003959_abnormal_lean_body | 0.44409159 |
| 158 | MP0005058_abnormal_lysosome_morphology | 0.44063883 |
| 159 | MP0009785_altered_susceptibility_to | 0.43753180 |
| 160 | MP0002295_abnormal_pulmonary_circulatio | 0.42468940 |
| 161 | MP0005464_abnormal_platelet_physiology | 0.42173801 |
| 162 | MP0003436_decreased_susceptibility_to | 0.41695469 |
| 163 | MP0002098_abnormal_vibrissa_morphology | 0.40561002 |
| 164 | MP0003953_abnormal_hormone_level | 0.40538291 |
| 165 | MP0002168_other_aberrant_phenotype | 0.39345707 |
| 166 | MP0009384_cardiac_valve_regurgitation | 0.39006048 |
| 167 | MP0005595_abnormal_vascular_smooth | 0.37443146 |
| 168 | MP0000538_abnormal_urinary_bladder | 0.36919374 |
| 169 | MP0002060_abnormal_skin_morphology | 0.36498721 |
| 170 | MP0005164_abnormal_response_to | 0.36445091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.34304265 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.91506972 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.55029739 |
| 4 | Xanthomatosis (HP:0000991) | 5.16754527 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.08733594 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.86882817 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.64261758 |
| 8 | Pancreatic cysts (HP:0001737) | 4.58792714 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.51516483 |
| 10 | Hyperglycinuria (HP:0003108) | 4.22252750 |
| 11 | Hyperglycinemia (HP:0002154) | 4.14994384 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.14474249 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.14474249 |
| 14 | Hyperammonemia (HP:0001987) | 4.05948037 |
| 15 | Joint hemorrhage (HP:0005261) | 4.05873435 |
| 16 | Pancreatic fibrosis (HP:0100732) | 4.04017729 |
| 17 | Complement deficiency (HP:0004431) | 4.02677092 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.98473266 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98459910 |
| 20 | Ketosis (HP:0001946) | 3.94509041 |
| 21 | True hermaphroditism (HP:0010459) | 3.82085244 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.77390765 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.72167157 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.65930780 |
| 25 | Epidermoid cyst (HP:0200040) | 3.64082018 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.63618823 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 3.63284568 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 3.63284568 |
| 29 | Concave nail (HP:0001598) | 3.63007745 |
| 30 | Abnormality of the renal cortex (HP:0011035) | 3.57447085 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52624027 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.47784178 |
| 33 | Fat malabsorption (HP:0002630) | 3.46363251 |
| 34 | Type II lissencephaly (HP:0007260) | 3.45113266 |
| 35 | Gaze-evoked nystagmus (HP:0000640) | 3.44927497 |
| 36 | Nephronophthisis (HP:0000090) | 3.42293119 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.40475262 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.39092097 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38713768 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.34092273 |
| 41 | Abnormality of the renal medulla (HP:0100957) | 3.24429884 |
| 42 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.24321542 |
| 43 | Abnormality of alanine metabolism (HP:0010916) | 3.24321542 |
| 44 | Hyperalaninemia (HP:0003348) | 3.24321542 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.22994472 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 3.22994472 |
| 47 | Decreased circulating renin level (HP:0003351) | 3.21727779 |
| 48 | Hyperventilation (HP:0002883) | 3.16572298 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 3.16111862 |
| 50 | Tubular atrophy (HP:0000092) | 3.13429480 |
| 51 | Delayed CNS myelination (HP:0002188) | 3.06916959 |
| 52 | Cerebral edema (HP:0002181) | 3.06226869 |
| 53 | Large for gestational age (HP:0001520) | 3.04691336 |
| 54 | Abolished electroretinogram (ERG) (HP:0000550) | 3.03030779 |
| 55 | Lethargy (HP:0001254) | 3.01616123 |
| 56 | Ketoacidosis (HP:0001993) | 2.99449380 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.98833704 |
| 58 | Progressive cerebellar ataxia (HP:0002073) | 2.92611004 |
| 59 | Cystic liver disease (HP:0006706) | 2.90693972 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.85270154 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.85144141 |
| 62 | Metabolic acidosis (HP:0001942) | 2.84903282 |
| 63 | Abnormality of complement system (HP:0005339) | 2.84181645 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.84040129 |
| 65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.80328862 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.78563138 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.77680276 |
| 68 | Steatorrhea (HP:0002570) | 2.75720306 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.74351901 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.72921604 |
| 71 | Abnormality of urine glucose concentration (HP:0011016) | 2.71768869 |
| 72 | Glycosuria (HP:0003076) | 2.71768869 |
| 73 | Genetic anticipation (HP:0003743) | 2.70538706 |
| 74 | Furrowed tongue (HP:0000221) | 2.66857838 |
| 75 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.66453150 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 2.65728519 |
| 77 | Cerebellar dysplasia (HP:0007033) | 2.64255633 |
| 78 | Renal cortical cysts (HP:0000803) | 2.60933925 |
| 79 | Vascular calcification (HP:0004934) | 2.55363912 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 2.52210013 |
| 81 | Gout (HP:0001997) | 2.51214487 |
| 82 | Acute encephalopathy (HP:0006846) | 2.50393363 |
| 83 | Hepatic necrosis (HP:0002605) | 2.48558379 |
| 84 | Pendular nystagmus (HP:0012043) | 2.48539829 |
| 85 | Keratoconus (HP:0000563) | 2.47310103 |
| 86 | Increased corneal curvature (HP:0100692) | 2.47310103 |
| 87 | Hypoglycemic seizures (HP:0002173) | 2.45724679 |
| 88 | Vomiting (HP:0002013) | 2.43894149 |
| 89 | Enlarged kidneys (HP:0000105) | 2.43545390 |
| 90 | Severe muscular hypotonia (HP:0006829) | 2.42392080 |
| 91 | Polydipsia (HP:0001959) | 2.40097935 |
| 92 | Abnormal drinking behavior (HP:0030082) | 2.40097935 |
| 93 | Spontaneous abortion (HP:0005268) | 2.36206353 |
| 94 | Congenital, generalized hypertrichosis (HP:0004540) | 2.34028880 |
| 95 | Hypoplasia of the pons (HP:0012110) | 2.33772767 |
| 96 | Opisthotonus (HP:0002179) | 2.33590936 |
| 97 | Alkalosis (HP:0001948) | 2.33071434 |
| 98 | Abnormality of the pons (HP:0007361) | 2.32567107 |
| 99 | Clumsiness (HP:0002312) | 2.32247612 |
| 100 | Sclerocornea (HP:0000647) | 2.31195226 |
| 101 | Congenital hepatic fibrosis (HP:0002612) | 2.30103450 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.27180482 |
| 103 | Abnormality of macular pigmentation (HP:0008002) | 2.26880320 |
| 104 | Myocardial infarction (HP:0001658) | 2.26168042 |
| 105 | Pancreatitis (HP:0001733) | 2.24395083 |
| 106 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.24284755 |
| 107 | Rickets (HP:0002748) | 2.23111334 |
| 108 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.23030036 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 2.22160875 |
| 110 | Hypochromic microcytic anemia (HP:0004840) | 2.19458489 |
| 111 | Inability to walk (HP:0002540) | 2.19131743 |
| 112 | Cardiovascular calcification (HP:0011915) | 2.18724477 |
| 113 | Hepatocellular carcinoma (HP:0001402) | 2.17019291 |
| 114 | Decreased central vision (HP:0007663) | 2.16430883 |
| 115 | Chronic hepatic failure (HP:0100626) | 2.15436779 |
| 116 | Amelogenesis imperfecta (HP:0000705) | 2.14853142 |
| 117 | Amyloidosis (HP:0011034) | 2.12953733 |
| 118 | Renal Fanconi syndrome (HP:0001994) | 2.12153287 |
| 119 | Congenital sensorineural hearing impairment (HP:0008527) | 2.11216256 |
| 120 | Hamartoma of the eye (HP:0010568) | 2.08767194 |
| 121 | Irritability (HP:0000737) | 2.08613893 |
| 122 | Axonal loss (HP:0003447) | 2.08484915 |
| 123 | Male pseudohermaphroditism (HP:0000037) | 2.08342329 |
| 124 | Abnormal biliary tract physiology (HP:0012439) | 2.07266541 |
| 125 | Bile duct proliferation (HP:0001408) | 2.07266541 |
| 126 | Increased muscle lipid content (HP:0009058) | 2.06125245 |
| 127 | Brushfield spots (HP:0001088) | 2.03057460 |
| 128 | Lipid accumulation in hepatocytes (HP:0006561) | 2.01174154 |
| 129 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99354611 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98335051 |
| 131 | Nausea (HP:0002018) | 1.98174078 |
| 132 | Stomach cancer (HP:0012126) | 1.98075703 |
| 133 | Elevated hepatic transaminases (HP:0002910) | 1.96009837 |
| 134 | Chorioretinal atrophy (HP:0000533) | 1.95744373 |
| 135 | Hyperuricemia (HP:0002149) | 1.95236240 |
| 136 | Increased purine levels (HP:0004368) | 1.95236240 |
| 137 | Skin nodule (HP:0200036) | 1.93729905 |
| 138 | Hyperphosphaturia (HP:0003109) | 1.93593121 |
| 139 | Increased CSF lactate (HP:0002490) | 1.93522111 |
| 140 | Hepatocellular necrosis (HP:0001404) | 1.93432506 |
| 141 | Glomerulonephritis (HP:0000099) | 1.92940750 |
| 142 | Methylmalonic aciduria (HP:0012120) | 1.92892690 |
| 143 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.92622914 |
| 144 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.92305248 |
| 145 | Progressive inability to walk (HP:0002505) | 1.91395967 |
| 146 | Patellar aplasia (HP:0006443) | 1.90664828 |
| 147 | Gingival bleeding (HP:0000225) | 1.90654404 |
| 148 | Anencephaly (HP:0002323) | 1.89858048 |
| 149 | Protruding tongue (HP:0010808) | 1.89577935 |
| 150 | Tubulointerstitial nephritis (HP:0001970) | 1.89079592 |
| 151 | Parakeratosis (HP:0001036) | 1.88978581 |
| 152 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88767397 |
| 153 | Symptomatic seizures (HP:0011145) | 1.88380553 |
| 154 | Mitochondrial inheritance (HP:0001427) | 1.88203314 |
| 155 | Broad-based gait (HP:0002136) | 1.87725711 |
| 156 | Abnormal protein glycosylation (HP:0012346) | 1.87509130 |
| 157 | Abnormal glycosylation (HP:0012345) | 1.87509130 |
| 158 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.87509130 |
| 159 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.87509130 |
| 160 | Tinnitus (HP:0000360) | 1.87239132 |
| 161 | Malnutrition (HP:0004395) | 1.87119613 |
| 162 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.86775282 |
| 163 | Abnormality of vitamin metabolism (HP:0100508) | 1.86650384 |
| 164 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.84701172 |
| 165 | Abnormal gallbladder morphology (HP:0012437) | 1.84301475 |
| 166 | Gait imbalance (HP:0002141) | 1.84055719 |
| 167 | Tachypnea (HP:0002789) | 1.83654107 |
| 168 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.83452958 |
| 169 | Hypertriglyceridemia (HP:0002155) | 1.83401932 |
| 170 | Flat capital femoral epiphysis (HP:0003370) | 1.82497573 |
| 171 | Lactic acidosis (HP:0003128) | 1.82424837 |
| 172 | Conjunctival hamartoma (HP:0100780) | 1.81845405 |
| 173 | Fair hair (HP:0002286) | 1.81358444 |
| 174 | Microretrognathia (HP:0000308) | 1.81091908 |
| 175 | Postaxial foot polydactyly (HP:0001830) | 1.81003920 |
| 176 | Methylmalonic acidemia (HP:0002912) | 1.79758956 |
| 177 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79669720 |
| 178 | Absent/shortened dynein arms (HP:0200106) | 1.79669720 |
| 179 | Abnormality of renal resorption (HP:0011038) | 1.79592091 |
| 180 | Tubulointerstitial fibrosis (HP:0005576) | 1.79489182 |
| 181 | Hydroxyprolinuria (HP:0003080) | 1.78697771 |
| 182 | Abnormality of proline metabolism (HP:0010907) | 1.78697771 |
| 183 | Pili torti (HP:0003777) | 1.76738296 |
| 184 | Congenital primary aphakia (HP:0007707) | 1.76018947 |
| 185 | Lissencephaly (HP:0001339) | 1.74175856 |
| 186 | Hypoplasia of the fovea (HP:0007750) | 1.72982858 |
| 187 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.72982858 |
| 188 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.72564242 |
| 189 | Hemiparesis (HP:0001269) | 1.72112588 |
| 190 | Generalized hypopigmentation of hair (HP:0011358) | 1.71830286 |
| 191 | Polyuria (HP:0000103) | 1.71655940 |
| 192 | Type I transferrin isoform profile (HP:0003642) | 1.70346599 |
| 193 | Hypoplasia of the uterus (HP:0000013) | 1.66388299 |
| 194 | Acute necrotizing encephalopathy (HP:0006965) | 1.64215488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.27370674 |
| 2 | IRAK3 | 3.54198722 |
| 3 | INSRR | 3.16738079 |
| 4 | MAPKAPK3 | 3.08947191 |
| 5 | STK16 | 2.65611997 |
| 6 | ACVR1B | 2.65267018 |
| 7 | TLK1 | 2.56081648 |
| 8 | PIK3CG | 2.45038211 |
| 9 | MAP4K2 | 2.38101281 |
| 10 | WNK4 | 2.25599453 |
| 11 | SIK1 | 2.22404361 |
| 12 | STK39 | 2.19206596 |
| 13 | FGFR4 | 2.18893703 |
| 14 | OXSR1 | 2.15594079 |
| 15 | EPHB1 | 2.14512701 |
| 16 | TIE1 | 2.08205008 |
| 17 | MST1R | 1.88693922 |
| 18 | PBK | 1.87829780 |
| 19 | ERN1 | 1.74659118 |
| 20 | MAPK13 | 1.72628335 |
| 21 | IRAK4 | 1.72091635 |
| 22 | GRK1 | 1.69626397 |
| 23 | ERBB4 | 1.65369335 |
| 24 | MAPK15 | 1.59378389 |
| 25 | IRAK2 | 1.58992421 |
| 26 | IRAK1 | 1.57510341 |
| 27 | DAPK2 | 1.57069555 |
| 28 | TAOK3 | 1.52814279 |
| 29 | NME2 | 1.48308503 |
| 30 | WNK3 | 1.46231281 |
| 31 | CASK | 1.44483860 |
| 32 | VRK2 | 1.43847784 |
| 33 | PKN1 | 1.43438932 |
| 34 | KDR | 1.39051590 |
| 35 | ADRBK2 | 1.36255471 |
| 36 | FER | 1.33959754 |
| 37 | MAP3K14 | 1.26813875 |
| 38 | PRKAA2 | 1.22407058 |
| 39 | ABL2 | 1.19541886 |
| 40 | MYLK | 1.17173374 |
| 41 | PHKG1 | 1.16805639 |
| 42 | PHKG2 | 1.16805639 |
| 43 | FRK | 1.15674867 |
| 44 | MAPK11 | 1.15176736 |
| 45 | PNCK | 1.15033861 |
| 46 | PRKCI | 1.14987584 |
| 47 | PINK1 | 1.14827922 |
| 48 | EPHA2 | 1.12853566 |
| 49 | MUSK | 1.09708744 |
| 50 | MAPKAPK5 | 1.09302919 |
| 51 | ADRBK1 | 1.08067192 |
| 52 | PAK3 | 1.07310554 |
| 53 | MET | 1.06585682 |
| 54 | TYK2 | 1.06392044 |
| 55 | STK38L | 1.05486982 |
| 56 | RPS6KB2 | 1.04270617 |
| 57 | NUAK1 | 1.04122838 |
| 58 | FGFR2 | 1.03472073 |
| 59 | IKBKE | 1.01480732 |
| 60 | PIK3CA | 0.99922218 |
| 61 | VRK1 | 0.97555088 |
| 62 | MST4 | 0.97131492 |
| 63 | BRSK2 | 0.97088723 |
| 64 | NTRK3 | 0.94422248 |
| 65 | ZAK | 0.93771681 |
| 66 | PTK2B | 0.93375528 |
| 67 | NLK | 0.85706547 |
| 68 | BLK | 0.84513706 |
| 69 | BMPR2 | 0.84010948 |
| 70 | TEC | 0.83900127 |
| 71 | TNK2 | 0.82451249 |
| 72 | MAPK4 | 0.81690093 |
| 73 | CAMK2G | 0.80664264 |
| 74 | TBK1 | 0.80544362 |
| 75 | CSNK1G1 | 0.79200064 |
| 76 | WEE1 | 0.75767080 |
| 77 | TXK | 0.74047339 |
| 78 | PRKCG | 0.72995374 |
| 79 | GRK7 | 0.72801105 |
| 80 | TNIK | 0.71623624 |
| 81 | TRIM28 | 0.70714839 |
| 82 | PRKCQ | 0.70491387 |
| 83 | OBSCN | 0.69441763 |
| 84 | CAMKK2 | 0.68811640 |
| 85 | SGK494 | 0.68417850 |
| 86 | SGK223 | 0.68417850 |
| 87 | EIF2AK2 | 0.67987119 |
| 88 | ERBB2 | 0.66077394 |
| 89 | TGFBR1 | 0.65796271 |
| 90 | GRK5 | 0.64864505 |
| 91 | CSNK1G3 | 0.64621829 |
| 92 | IKBKB | 0.63413337 |
| 93 | CSK | 0.61065313 |
| 94 | EPHA3 | 0.60892753 |
| 95 | TGFBR2 | 0.60197909 |
| 96 | MAP3K3 | 0.59831295 |
| 97 | BCR | 0.59824904 |
| 98 | MAP2K4 | 0.59077612 |
| 99 | TRPM7 | 0.57018029 |
| 100 | MAPK7 | 0.56747044 |
| 101 | MAPK12 | 0.56542615 |
| 102 | AKT3 | 0.54366713 |
| 103 | CSNK1A1 | 0.53883663 |
| 104 | LATS1 | 0.53807234 |
| 105 | CAMK1 | 0.52885705 |
| 106 | LIMK1 | 0.52616104 |
| 107 | GSK3A | 0.51677492 |
| 108 | CAMK2D | 0.50949534 |
| 109 | NEK9 | 0.50773486 |
| 110 | MAP2K1 | 0.50115635 |
| 111 | PRKD2 | 0.47888998 |
| 112 | PKN2 | 0.47525216 |
| 113 | MAP2K2 | 0.47056553 |
| 114 | PRKACG | 0.46863466 |
| 115 | MAP2K6 | 0.46379129 |
| 116 | MKNK2 | 0.46080476 |
| 117 | CSF1R | 0.46069654 |
| 118 | BMPR1B | 0.45631764 |
| 119 | LYN | 0.45378389 |
| 120 | PRKCE | 0.44596799 |
| 121 | NEK6 | 0.43215163 |
| 122 | PRKACA | 0.42624980 |
| 123 | RPS6KA5 | 0.42605018 |
| 124 | EPHB2 | 0.42507734 |
| 125 | CAMK2B | 0.42422846 |
| 126 | FLT3 | 0.42299274 |
| 127 | STK3 | 0.41468106 |
| 128 | JAK1 | 0.40741378 |
| 129 | CHUK | 0.40041877 |
| 130 | BTK | 0.39154514 |
| 131 | CAMK2A | 0.39094980 |
| 132 | PRKCZ | 0.38298965 |
| 133 | PRKCA | 0.38218213 |
| 134 | IGF1R | 0.38215481 |
| 135 | EPHA4 | 0.38119374 |
| 136 | MAP3K4 | 0.37730167 |
| 137 | MAP2K3 | 0.37610627 |
| 138 | CAMK1D | 0.36814960 |
| 139 | GRK6 | 0.36487243 |
| 140 | MAP4K1 | 0.36143023 |
| 141 | CSNK1D | 0.35882046 |
| 142 | KIT | 0.35636301 |
| 143 | DYRK2 | 0.35591433 |
| 144 | CSNK1A1L | 0.34278697 |
| 145 | JAK2 | 0.33921669 |
| 146 | PRKAA1 | 0.33734097 |
| 147 | CSNK1G2 | 0.31049490 |
| 148 | PRKG1 | 0.30414281 |
| 149 | STK11 | 0.28799293 |
| 150 | SGK2 | 0.28439936 |
| 151 | CAMKK1 | 0.27298733 |
| 152 | ITK | 0.25338999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.81779022 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.91180046 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90406982 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.71475636 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56917274 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.52124666 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50264472 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48012569 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46948471 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.44585571 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.43866199 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.40220614 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.36934438 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.33841710 |
| 15 | * Peroxisome_Homo sapiens_hsa04146 | 2.32676764 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.23678002 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23266121 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20599956 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19488817 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10479760 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07881142 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07621900 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.02701088 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91785313 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90034768 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88657370 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86772415 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86125576 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84339393 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.77156256 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.73480129 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.72951734 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72612913 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.66414512 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65533070 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55595401 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53296884 |
| 38 | RNA polymerase_Homo sapiens_hsa03020 | 1.52002489 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51213049 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50958027 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50276731 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.49638239 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39101484 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.38729867 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37172748 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27837339 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24728160 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.23136260 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22739014 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19979806 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18709582 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.18411518 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18107090 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17704155 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14908592 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 1.14579326 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14435089 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13300345 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13122186 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12512464 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10771948 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.10338730 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 1.10288801 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09806996 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06681089 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04211091 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00220599 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97925000 |
| 69 | Insulin secretion_Homo sapiens_hsa04911 | 0.97058060 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96456583 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94910703 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.88580621 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80750868 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.78871466 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.78025527 |
| 76 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77588377 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75446198 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74447359 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73019891 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72274683 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71821636 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70158636 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69319685 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69261283 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69182153 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64936185 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61777593 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60810602 |
| 89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59533359 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.58669306 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.57421665 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56402880 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56008965 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54531041 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.53692310 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.53175451 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51067682 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46613077 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44394193 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43773509 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42628299 |
| 102 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42424782 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39434325 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37898576 |
| 105 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37707858 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36800580 |
| 107 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36796019 |
| 108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36422506 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32164822 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29962731 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29501949 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.29283710 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25365883 |
| 114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.20692802 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18199487 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13016714 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12920469 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.11145409 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.09387702 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08801573 |
| 121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.06217423 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05321861 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.03914922 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.03099302 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01739065 |
| 126 | Ribosome_Homo sapiens_hsa03010 | 0.00648092 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1245656 |
| 128 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1137276 |
| 129 | Lysosome_Homo sapiens_hsa04142 | -0.1107036 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0903457 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | -0.0698127 |
| 132 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0652283 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0330677 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | -0.0172147 |

